Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Verotta

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1989
Pharmacodynamic modeling of verapamil effects under steady-state and nonsteady-state conditionsJ B Schwartz, D Verotta, L B Sheiner
Biometrics|December 1, 1995
A new method to explore the distribution of interindividual random effects in non-linear mixed effects modelsK E Fattinger, L B Sheiner, D Verotta
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1991
Mean time parameters for generalized physiological flow models (semihomogeneous linear systems)D Verotta, L B Sheiner, S L Beal
Journal of Pharmaceutical Sciences|May 18, 2001
A semiparametric deconvolution model to establish in vivo-in vitro correlation applied to OROS oxybutyninM Pitsiu, G Sathyan, S Gupta, et al.
Anesthesiology|May 1, 1990
Comparative tissue concentration profiles of fentanyl and alfentanil in humans predicted from tissue/blood partition data obtained in ratsS Björkman, D R Stanski, D Verotta, et al.
Journal of Pharmacokinetics and Biopharmaceutics|April 24, 1999
Use of a pharmacokinetic/pharmacodynamic model to design an optimal dose input profileK Park, D Verotta, S K Gupta, et al.
Journal of Pharmaceutical Sciences|April 1, 1996
A descriptive tool to characterize nonlinear kinetics, with applications to meperidine and lidocaineJ M Gries, R Upton, Y F Huang, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2001
Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncomplianceJ Lu, J M Gries, D Verotta, et al.
British Journal of Clinical Pharmacology|March 9, 2005
Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjectsC Csajka, C A Haller, N L Benowitz, et al.
European Journal of Clinical Pharmacology|August 23, 2000
Nasal mucosal versus gastrointestinal absorption of nasally administered cocaineK Fattinger, N L Benowitz, R T Jones, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1989
Pharmacodynamic modeling of verapamil effects under steady-state and nonsteady-state conditionsJ B Schwartz, D Verotta, L B Sheiner
Biometrics|December 1, 1995
A new method to explore the distribution of interindividual random effects in non-linear mixed effects modelsK E Fattinger, L B Sheiner, D Verotta
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1991
Mean time parameters for generalized physiological flow models (semihomogeneous linear systems)D Verotta, L B Sheiner, S L Beal
Journal of Pharmaceutical Sciences|May 18, 2001
A semiparametric deconvolution model to establish in vivo-in vitro correlation applied to OROS oxybutyninM Pitsiu, G Sathyan, S Gupta, et al.
Anesthesiology|May 1, 1990
Comparative tissue concentration profiles of fentanyl and alfentanil in humans predicted from tissue/blood partition data obtained in ratsS Björkman, D R Stanski, D Verotta, et al.
Journal of Pharmacokinetics and Biopharmaceutics|April 24, 1999
Use of a pharmacokinetic/pharmacodynamic model to design an optimal dose input profileK Park, D Verotta, S K Gupta, et al.
Journal of Pharmaceutical Sciences|April 1, 1996
A descriptive tool to characterize nonlinear kinetics, with applications to meperidine and lidocaineJ M Gries, R Upton, Y F Huang, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2001
Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncomplianceJ Lu, J M Gries, D Verotta, et al.
British Journal of Clinical Pharmacology|March 9, 2005
Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjectsC Csajka, C A Haller, N L Benowitz, et al.
European Journal of Clinical Pharmacology|August 23, 2000
Nasal mucosal versus gastrointestinal absorption of nasally administered cocaineK Fattinger, N L Benowitz, R T Jones, et al.
Pageof 7